Skip to main content
Clinical Trials/NL-OMON54534
NL-OMON54534
Recruiting
N/A

Permanent left ventricular septal pacing versus right ventricular pacing in patients with atrioventricular conduction disorders: a randomized trial: LEAP trial. - LEAP trial.

niversiteit Maastricht0 sites400 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversiteit Maastricht
Enrollment
400
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age \>\=18 years with a life expectancy with good functional status of at least
  • \- Class I or class IIa permanent pacing indication owing to an AV conduction
  • disorder with an expected ventricular pacing percentage of \>\= 20%. AV conduction
  • disorders include:
  • \- acquired third\- or second\-degree AV block.
  • \- atrial arrhythmia with slow ventricular conduction.
  • \- LVEF \>\= 40%.
  • \- Signed and dated informed consent form prior to admission to the trial.

Exclusion Criteria

  • \- Heart failure NYHA class III\-IV
  • \- Class I indication for cardiac resynchronization therapy
  • \- Class I indication for implantable cardioverter defibrillator
  • \- Previous receipt of a cardiac implantable electronic device (except for
  • implantable loop recorders)
  • \- Atrial arrhythmia with planned AV junction ablation
  • \- Unstable angina or acute myocardial infarction
  • \- Percutaneous or surgical coronary intervention within 30 days before
  • \- Valvular disease with an indication for valve repair or replacement
  • \- Hypertrophic cardiomyopathy with septal wall diameter \> 2 cm

Outcomes

Primary Outcomes

Not specified

Similar Trials